AARON SLYH: Open Payments
NPI 1922757665 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 28 payments from 13 companies in 2025. Trend: 2023 $615 · 2024 $245 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Dexcom, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| TOLMAR, INC. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: Auvelity, HETLIOZ, Dexcom G6 Transmitter, XIFAXAN, VRAYLAR, CAPLYTA, JATENZO, Jornay PM.
Industry payments across KY — which companies pay providers there.
